NCT03001999
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,005 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
NCT02406443
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- University Health Network - Division of Nephrology Toronto, Ontario, Canada
NCT02551900
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Laemchabang stadium, Sukhumvit Rd Si Racha, Changwat Chon Buri, Thailand
NCT01680341
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Goodyear, Arizona, United States
- Novo Nordisk Investigational Site Anaheim, California, United States
- Novo Nordisk Investigational Site Greenbrae, California, United States
- Novo Nordisk Investigational Site San Diego, California, United States
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Greenbrae, California, United States
- Novo Nordisk Investigational Site Mission Hills, California, United States
- Novo Nordisk Investigational Site San Diego, California, United States
- Novo Nordisk Investigational Site Kissimmee, Florida, United States
NCT03475069
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
- Locations
-
- Başar Öztürk Istanbul, Turkey (Türkiye)
NCT02420262
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
- Novo Nordisk Investigational Site Anaheim, California, United States
- Novo Nordisk Investigational Site Bermuda Dunes, California, United States
- Novo Nordisk Investigational Site Fresno, California, United States
Completed
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
NCT02917057
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Optum Epidemiology Boston, Massachusetts, United States
Completed
Preferred Treatment of Type 1.5 Diabetes
NCT00194896
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- DVA Puget Sound Health Care System Seattle, Washington, United States
Completed
Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes
NCT01690091
- Conditions
- Chronic Heart Failure, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Diabetes Center, Institute of Clinical and Experimental Medicine Prague, Czechia